T cells - EpiVax, Inc. - Informatics and Immunology

Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease

Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease

by Riley Nolan | Jun 22, 2021

Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs

Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs

by Riley Nolan | Apr 20, 2021

Differential functional patterns of memory CD4+ and CD8+ T-cells from volunteers immunized with Ty21a typhoid vaccine observed using a recombinant Escherichia coli system expressing S. Typhi proteins

Differential functional patterns of memory CD4+ and CD8+ T-cells from volunteers immunized with Ty21a typhoid vaccine observed using a recombinant Escherichia coli system expressing S. Typhi proteins

by Annie De Groot | Jan 13, 2020

Differential functional patterns of memory CD4+ and CD8+ T-cells

Highly Conserved Influenza T Cell Epitopes Induce Broadly Protective Immunity

Highly Conserved Influenza T Cell Epitopes Induce Broadly Protective Immunity

by Annie De Groot | Jul 23, 2019

Highly Conserved Influenza T Cell Epitopes Induce Broadly Protective Immunity

Disease Status Explained by Neo-epitopes with Low Potential for Activating Regulatory T cells: an Application of Precision Cancer Immunotherapy Design Tools to Bladder Cancer

Disease Status Explained by Neo-epitopes with Low Potential for Activating Regulatory T cells: an Application of Precision Cancer Immunotherapy Design Tools to Bladder Cancer

by Annie De Groot | Oct 8, 2018

EpiVax_poster_Disease Status Explained by Neo-Epitopes with Low Potential for Activating Regulatory T Cells

« Older Entries